Yuko Oyama

694 total citations
32 papers, 531 citations indexed

About

Yuko Oyama is a scholar working on Nephrology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yuko Oyama has authored 32 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Nephrology, 11 papers in Molecular Biology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yuko Oyama's work include Renal Diseases and Glomerulopathies (8 papers), Parathyroid Disorders and Treatments (4 papers) and Chronic Kidney Disease and Diabetes (4 papers). Yuko Oyama is often cited by papers focused on Renal Diseases and Glomerulopathies (8 papers), Parathyroid Disorders and Treatments (4 papers) and Chronic Kidney Disease and Diabetes (4 papers). Yuko Oyama collaborates with scholars based in Japan, United States and Vietnam. Yuko Oyama's co-authors include Masahiko Kurabayashi, Ryozo Nagai, Mahito Sato, Nobuhiro Akuzawa, Hiroko Sato, Fumitake Gejyo, Hironosuke Sakamoto, Noriaki Iino, Keiko Kawai‐Kowase and Hiroyoshi Kanai and has published in prestigious journals such as Circulation Research, Journal of the American Society of Nephrology and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Yuko Oyama

30 papers receiving 516 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuko Oyama Japan 13 242 130 91 84 75 32 531
Carolina Lavoz Spain 15 352 1.5× 171 1.3× 98 1.1× 70 0.8× 63 0.8× 26 738
Ana M. Blázquez‐Medela United States 15 281 1.2× 105 0.8× 66 0.7× 103 1.2× 95 1.3× 24 701
Leilani E. Beltran United Kingdom 6 205 0.8× 96 0.7× 60 0.7× 41 0.5× 43 0.6× 6 454
Edgar Maquigussa Brazil 12 218 0.9× 111 0.9× 93 1.0× 50 0.6× 57 0.8× 28 456
Toshinori Ueno Japan 15 291 1.2× 216 1.7× 157 1.7× 44 0.5× 71 0.9× 29 687
Yoshiki Akakabe Japan 10 155 0.6× 67 0.5× 77 0.8× 144 1.7× 42 0.6× 18 429
Riccardo Albertini Italy 10 389 1.6× 125 1.0× 57 0.6× 29 0.3× 116 1.5× 11 658
Tania Polhill Australia 12 298 1.2× 177 1.4× 69 0.8× 29 0.3× 48 0.6× 13 611
Silvia Berra Italy 10 178 0.7× 229 1.8× 60 0.7× 33 0.4× 56 0.7× 21 529
Nabil A. Rashdan United States 13 197 0.8× 57 0.4× 65 0.7× 80 1.0× 58 0.8× 18 460

Countries citing papers authored by Yuko Oyama

Since Specialization
Citations

This map shows the geographic impact of Yuko Oyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuko Oyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuko Oyama more than expected).

Fields of papers citing papers by Yuko Oyama

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuko Oyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuko Oyama. The network helps show where Yuko Oyama may publish in the future.

Co-authorship network of co-authors of Yuko Oyama

This figure shows the co-authorship network connecting the top 25 collaborators of Yuko Oyama. A scholar is included among the top collaborators of Yuko Oyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuko Oyama. Yuko Oyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Oyama, Yuko, et al.. (2024). A case of non-lupus full-house nephropathy diagnosed by kidney biopsy but observed IgA nephropathy on second biopsy. CEN Case Reports. 13(5). 373–380. 1 indexed citations
3.
4.
5.
6.
7.
8.
Oyama, Yuko, et al.. (2016). A Case of Transforming Growth Factor-β-Induced Gene-Related Oculorenal Syndrome: Granular Corneal Dystrophy Type II with a Unique Nephropathy. Case Reports in Nephrology and Dialysis. 6(3). 106–113. 3 indexed citations
9.
Masai, Rie, Hideki Wakui, Atsushi Komatsuda, et al.. (2009). Characteristics of proliferative glomerulo-nephritis with monoclonal IgG deposits associated with membranoproliferative features. Clinical Nephrology. 72(7). 46–54. 23 indexed citations
10.
Oyama, Yuko, T. Takeda, Hitomi Hama, et al.. (2005). Evidence for megalin-mediated proximal tubular uptake of L-FABP, a carrier of potentially nephrotoxic molecules. Laboratory Investigation. 85(4). 522–531. 70 indexed citations
11.
Oyama, Yuko, Junichiro James Kazama, Kentaro Omori, et al.. (2005). Pretreatment plasma intact parathyroid hormone and serum calcium levels, but not serum phosphate levels, predict the response to maxacalcitol therapy in dialysis patients with secondary hyperparathyroidism. Clinical and Experimental Nephrology. 9(2). 142–147. 4 indexed citations
12.
Bhogal, B., Yuko Oyama, Anna Powell, et al.. (2004). The correlation of indirect immunofluorescence, enzyme-linked immunosorbent assay and disease activity in pemphigus. British Journal of Dermatology. 151. 5–6. 1 indexed citations
13.
Maki, Nobuki, Atsushi Komatsuda, Hiromichi Wakui, et al.. (2004). A nonsense mutation (R220X) in the a-galactosidase A gene causes typical Fabry disease in both genders. Clinical Nephrology. 61(3). 185–190. 8 indexed citations
14.
Kawai‐Kowase, Keiko, Hiroko Sato, Yuko Oyama, et al.. (2004). Basic Fibroblast Growth Factor Antagonizes Transforming Growth Factor-β1–Induced Smooth Muscle Gene Expression Through Extracellular Signal–Regulated Kinase 1/2 Signaling Pathway Activation. Arteriosclerosis Thrombosis and Vascular Biology. 24(8). 1384–1390. 55 indexed citations
15.
Sakamoto, Hironosuke, Tetsuo Sakamaki, Tsugiyasu Kanda, et al.. (2004). Vascular Endothelial Growth Factor is an Autocrine Growth Factor for Cardiac Myxoma Cells. Circulation Journal. 68(5). 488–493. 44 indexed citations
16.
Oyama, Yuko, Keiko Kawai‐Kowase, Kenichi Sekiguchi, et al.. (2004). Homeobox Protein Hex Facilitates Serum Responsive Factor–Mediated Activation of the SM22α Gene Transcription in Embryonic Fibroblasts. Arteriosclerosis Thrombosis and Vascular Biology. 24(9). 1602–1607. 7 indexed citations
17.
Oyama, Yuko. (2003). Combined radioguided parathyroidectomy and intravenous vitamin D therapy for the treatment of uraemic hyperparathyroidism. Nephrology Dialysis Transplantation. 18(90003). 76iii–78. 4 indexed citations
18.
Saito, Akihiko, Junichiro James Kazama, Noriaki Iino, et al.. (2003). Bioengineered Implantation of Megalin-Expressing Cells. Journal of the American Society of Nephrology. 14(8). 2025–2032. 27 indexed citations
19.
Sekiguchi, Kenichi, Masahiko Kurabayashi, Yuko Oyama, et al.. (2001). Homeobox Protein Hex Induces SMemb/Nonmuscle Myosin Heavy Chain-B Gene Expression Through the cAMP-Responsive Element. Circulation Research. 88(1). 52–58. 40 indexed citations
20.
Nishi, Shinichi, Mitsuhiro Ueno, Hisaki Shimada, et al.. (2000). Ultrastructural characteristics of diabetic nephropathy. PubMed. 33(2). 65–73. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carolina Lavoz Breakdown of academic impact, for papers by Ana M. Blázquez‐Medela Breakdown of academic impact, for papers by Leilani E. Beltran Breakdown of academic impact, for papers by Edgar Maquigussa Breakdown of academic impact, for papers by Toshinori Ueno Breakdown of academic impact, for papers by Yoshiki Akakabe Breakdown of academic impact, for papers by Riccardo Albertini Breakdown of academic impact, for papers by Tania Polhill Breakdown of academic impact, for papers by Silvia Berra Breakdown of academic impact, for papers by Nabil A. Rashdan
Rankless by CCL
2026